Sotera Health Company (SHC)
NASDAQ: SHC · Real-Time Price · USD
11.30
+0.43 (3.96%)
Apr 24, 2025, 4:00 PM EDT - Market closed
Sotera Health Company Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for Sotera Health Company stock have an average target of 15.5, with a low estimate of 12 and a high estimate of 20. The average target predicts an increase of 37.17% from the current stock price of 11.30.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Sotera Health Company stock from 4 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 1 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 2 | 2 | 2 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 5 | 5 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Hold Maintains $15 → $13 | Hold | Maintains | $15 → $13 | +15.04% | Apr 23, 2025 |
| Barclays | Barclays | Buy Maintains $16 → $12 | Buy | Maintains | $16 → $12 | +6.19% | Apr 10, 2025 |
| Barclays | Barclays | Buy Maintains $17 → $16 | Buy | Maintains | $17 → $16 | +41.59% | Feb 28, 2025 |
| Barclays | Barclays | Buy Maintains $18 → $17 | Buy | Maintains | $18 → $17 | +50.44% | Feb 18, 2025 |
| RBC Capital | RBC Capital | Buy Reiterates $17 | Buy | Reiterates | $17 | +50.44% | Nov 21, 2024 |
Financial Forecast
Revenue This Year
1.14B
from 1.10B
Increased by 3.87%
Revenue Next Year
1.21B
from 1.14B
Increased by 5.77%
EPS This Year
0.75
from 0.16
Increased by 377.73%
EPS Next Year
0.85
from 0.75
Increased by 13.53%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 1.2B | 1.3B | 1.4B | |
| Avg | 1.1B | 1.2B | 1.3B | |
| Low | 1.1B | 1.2B | 1.2B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 9.1% | 11.2% | 11.8% | |
| Avg | 3.9% | 5.8% | 6.3% | |
| Low | 0.2% | 1.8% | 1.9% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 0.82 | 0.93 | 1.03 | |
| Avg | 0.75 | 0.85 | 0.95 | |
| Low | 0.71 | 0.79 | 0.88 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 422.3% | 24.3% | 21.0% | |
| Avg | 377.7% | 13.5% | 11.4% | |
| Low | 350.0% | 6.0% | 3.7% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.